1 / 18

Middle East Precision Medicine Market-Analysis and Forecast, 2022-2032

The Middle East precision medicine market was estimated to be at $3,942.6 million in 2021, which is expected to grow with a CAGR of 7.37% and reach $8,620.0 million by 2032.

bisreports
Download Presentation

Middle East Precision Medicine Market-Analysis and Forecast, 2022-2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Middle East Precision Medicine Market- Country Analysis Table of Content MIDDLE EAST PRECISION MEDICINE MARKET Focus on Ecosystem, Technology, Application, End User, and Country Data Analysis and Forecast: 2022-2032 May 2022 All rights reserved at BIS Research Inc. 1

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. MIDDLE EAST PRECISION MEDICINE MARKET Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. All rights reserved at BIS Research Inc. 2

  3. Table of Content Executive Summary .......................................................................... 20 1 Middle East Precision Medicine Market ...................................... 22 1.1 Product Definition ............................................................................................ 23 1.1.1Inclusion and Exclusion ............................................................................. 23 1.1.2Key Questions Answered in the Report .................................................... 23 1.2 Research Methodology ................................................................................... 24 1.2.1Primary Data Sources ................................................................................. 24 1.2.2Secondary Data Sources ............................................................................ 25 1.3 Market Estimation Model ................................................................................. 25 Market Overview ........................................................................ 28 2 2.1 Market Definition .............................................................................................. 29 2.2 Precision Medicine: A Frontier in the Genesis of Patient-Centric Medicine ........................................................................................................... 30 2.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy ......................................................................... 31 2.4 Precision Medicine: Enabling Technologies and Applications ................... 31 2.4.1Innovators .................................................................................................... 32 2.4.1.1 3D DNA Printing ................................................................................................ 32 2.4.1.1.1Introduction .............................................................................................................. 32 MIDDLE EAST PRECISION MEDICINE MARKET 2.4.1.1.2Role of 3D DNA Printing .......................................................................................... 32 2.4.1.2 RNA-Seq ............................................................................................................ 32 2.4.1.2.1Introduction .............................................................................................................. 32 2.4.1.2.2Role of RNA-Seq in Precision Medicine .................................................................. 32 2.4.1.2.3Key Players .............................................................................................................. 33 2.4.1.3 4D Molecular Imaging ........................................................................................ 33 2.4.1.3.1Introduction .............................................................................................................. 33 2.4.1.3.2Role of 4D Molecular Imaging in Precision Medicine .............................................. 33 2.4.1.3.3Key Players .............................................................................................................. 33 All rights reserved at BIS Research Inc. 3

  4. 2.4.2Early Adopters ............................................................................................. 33 2.4.2.1 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) ........... 33 2.4.2.1.1Introduction .............................................................................................................. 33 2.4.2.1.2Role of CRISPR in Precision Medicine .................................................................... 34 2.4.2.1.3Key Players .............................................................................................................. 34 2.4.2.2 Blockchain ......................................................................................................... 35 2.4.2.2.1Introduction .............................................................................................................. 35 2.4.2.2.2Role of Blockchain in Precision Medicine ................................................................ 35 2.4.2.2.3Key Players .............................................................................................................. 35 2.4.2.3 Imaging Informatics ........................................................................................... 36 2.4.2.3.1Introduction .............................................................................................................. 36 2.4.2.3.2Role of Imaging Informatics in Precision Medicine .................................................. 36 2.4.2.3.3Key Players .............................................................................................................. 36 2.4.3Early Majority ............................................................................................... 36 2.4.3.1 Artificial Intelligence (AI) .................................................................................... 36 2.4.3.1.1Introduction .............................................................................................................. 36 2.4.3.1.2Role of Artificial Intelligence in Precision Medicine .................................................. 37 2.4.3.1.3Key Players .............................................................................................................. 37 2.4.3.2 Circulating Free DNA (cfDNA) ........................................................................... 37 2.4.3.2.1Introduction .............................................................................................................. 37 2.4.3.2.2Role of cfDNA in Precision Medicine ....................................................................... 37 MIDDLE EAST PRECISION MEDICINE MARKET 2.4.3.2.3Key Players .............................................................................................................. 38 2.4.3.3 Big Data ............................................................................................................. 38 2.4.3.3.1Introduction .............................................................................................................. 38 2.4.3.3.2Role of Big Data in Precision Medicine .................................................................... 38 2.4.3.3.3Key Players .............................................................................................................. 39 2.4.3.4 Next-Generation Sequencing (NGS) ................................................................. 39 2.4.3.4.1Introduction .............................................................................................................. 39 2.4.3.4.2Role of NGS in Precision Medicine .......................................................................... 39 2.4.3.4.3Key Players .............................................................................................................. 39 All rights reserved at BIS Research Inc. 4

  5. 2.4.3.5 Health Informatics .............................................................................................. 40 2.4.3.5.1Introduction .............................................................................................................. 40 2.4.3.5.2Role of Health Informatics in Precision Medicine .................................................... 40 2.4.3.5.3Key players .............................................................................................................. 41 2.4.3.6 Bioinformatics .................................................................................................... 41 2.4.3.6.1Introduction .............................................................................................................. 41 2.4.3.6.2Role of Bioinformatics in Precision Medicine ........................................................... 41 2.4.3.6.3Key Players .............................................................................................................. 41 2.4.4Late Majority ................................................................................................ 42 2.4.4.1 Polymerase Chain Reactions (PCR) ................................................................. 42 2.4.4.1.1Introduction .............................................................................................................. 42 2.4.4.1.2Role of PCR in Precision Medicine .......................................................................... 42 2.4.4.1.3Key players .............................................................................................................. 42 2.4.4.2 Microarray .......................................................................................................... 42 2.4.4.2.1Role of Microarray in Precision Medicine ................................................................ 43 2.4.4.2.2Key Players .............................................................................................................. 43 2.5 COVID-19 Impact on the Middle East Precision Medicine Market ............... 43 Industry Insights ........................................................................ 45 3 3.1 Patent Analysis ................................................................................................ 46 3.2 Legal Requirements and Regulations ............................................................ 46 Competitive Landscape ............................................................. 48 4 MIDDLE EAST PRECISION MEDICINE MARKET 4.1 Synergistic Activities ...................................................................................... 49 4.2 Product Launches, Enhancements, and Upgradation .................................. 49 4.3 Mergers and Acquisitions ............................................................................... 50 4.4 Business Expansion ........................................................................................ 51 Market Dynamics ....................................................................... 53 5 5.1 Market Drivers .................................................................................................. 54 5.1.1Advancement of Sequencing Technologies ............................................. 54 5.1.2Rising Prevalence of Chronic Diseases .................................................... 54 5.1.3Shifting the Significance in Medicine from Reaction to Prevention ....... 55 All rights reserved at BIS Research Inc. 5

  6. 5.1.4Reducing Adverse Drug Reactions through Pharmacogenomics Test ............................................................................................................... 55 5.1.5Potential to Reduce the Overall Healthcare Cost Across the Globe ....... 56 5.2 Market Restraints ............................................................................................. 56 5.2.1Unified Framework for Data Integration .................................................... 56 5.2.2Limited Knowledge about Molecular Mechanism/Interaction ................. 57 5.2.3Lack of Robust Reimbursement Landscape ............................................. 58 5.3 Market Opportunities ....................................................................................... 58 5.3.1Targeted Gene Therapy .............................................................................. 58 5.3.2Expansion into Emerging Markets ............................................................. 59 5.3.3Collaborations and Partnerships across Value Chain to Accelerate Market Entry ................................................................................................. 60 Middle East Precision Medicine Market, by Ecosystem, $Million, 2021 - 2032 .................................................................. 61 6 6.1 Overview ........................................................................................................... 62 6.2 Applied Sciences ............................................................................................. 63 6.3 Precision Therapeutics ................................................................................... 65 6.4 Digital Health and Information Technology ................................................... 67 6.5 Precision Diagnostics ..................................................................................... 69 Middle East Precision Medicine Market, by Application, $Million, 2021 - 2032 .................................................................. 72 7 MIDDLE EAST PRECISION MEDICINE MARKET 7.1 Overview ........................................................................................................... 73 7.2 Oncology .......................................................................................................... 74 7.3 Infectious Diseases ......................................................................................... 76 7.4 Neurology ......................................................................................................... 77 7.5 Endocrinology .................................................................................................. 78 7.6 Cardiology ........................................................................................................ 79 7.7 Gastroenterology ............................................................................................. 80 7.8 Other Applications ........................................................................................... 81 Middle East Precision Medicine Market, by End-User, $Million, 2021 - 2032 ................................................................................ 83 8 All rights reserved at BIS Research Inc. 6

  7. 8.1 Overview ........................................................................................................... 84 8.2 Biopharmaceutical Companies ...................................................................... 85 8.3 Diagnostic Companies .................................................................................... 86 8.4 Other End Users .............................................................................................. 87 Middle East Precision Medicine Market, by Country, $Million, 2021-2032 .................................................................................. 88 9 9.1 Overview ........................................................................................................... 89 9.1.1K.S.A. ............................................................................................................ 90 9.1.2Israel ............................................................................................................. 92 9.1.3U.A.E. ............................................................................................................ 93 9.1.4Egypt ............................................................................................................ 94 9.1.5Iran ................................................................................................................ 95 9.1.6Qatar ............................................................................................................. 95 9.1.7Other Countries ........................................................................................... 96 10Market - Competitive Benchmarking & Company Profiles ........... 98 10.1Overview ........................................................................................................... 99 10.2Abbott. ............................................................................................................ 100 10.2.1Company Overview ................................................................................... 100 10.2.2Role of Abbott. in the Middle East Precision Medicine Market.............. 100 10.2.3Key Competitors of the Company ............................................................ 100 10.2.4Key Customers of the Company .............................................................. 101 MIDDLE EAST PRECISION MEDICINE MARKET 10.2.5Financials ................................................................................................... 101 10.2.6Key Insights about the Financial Health of the Company ...................... 103 10.2.7SWOT Analysis .......................................................................................... 104 10.3Bio-Rad Laboratories, Inc. ............................................................................ 105 10.3.1Company Overview ................................................................................... 105 10.3.2Role of Bio-Rad Laboratories, Inc. in the Middle East Precision Medicine Market......................................................................................... 105 10.3.3Key Competitors of the Company ............................................................ 105 10.3.4Key Customers of the Company .............................................................. 105 All rights reserved at BIS Research Inc. 7

  8. 10.3.5Business Strategies .................................................................................. 106 10.3.6Financials ................................................................................................... 106 10.3.7Key Insights about the Financial Health of the Company ...................... 108 10.3.8SWOT Analysis .......................................................................................... 109 10.4ASURAGEN, INC. ........................................................................................... 110 10.4.1Company Overview ................................................................................... 110 10.4.2Role of ASURAGEN, INC. in the Middle East Precision Medicine Market ......................................................................................................... 110 10.4.3Key Competitors of the Company ............................................................ 110 10.4.4Key Customers of the Company .............................................................. 110 10.4.5SWOT Analysis .......................................................................................... 111 10.5bioMérieux SA ................................................................................................ 112 10.5.1Company Overview ................................................................................... 112 10.5.2Role of bioMérieux SA in the Middle East Precision Medicine Market .................................................................................................................... 112 10.5.3Key Competitors of the Company ............................................................ 112 10.5.4Key Customers of the Company .............................................................. 112 10.5.5Financials ................................................................................................... 113 10.5.6Key Insights about the Financial Health of the Company ...................... 115 10.5.7SWOT Analysis .......................................................................................... 116 10.6Diginova Health Solutions Ltd. ..................................................................... 117 MIDDLE EAST PRECISION MEDICINE MARKET 10.6.1Company Overview ................................................................................... 117 10.6.2Role of Diginova Health Solutions Ltd. in the Middle East Precision Medicine Market......................................................................................... 117 10.6.3Key Competitors of the Company ............................................................ 118 10.6.4Key Customers of the Company .............................................................. 118 10.6.5Corporate Strategies ................................................................................. 118 10.6.5.1 Product Launches and Upgradation ................................................................ 118 10.6.6SWOT Analysis .......................................................................................... 119 10.7F. Hoffmann-La Roche Ltd ............................................................................ 120 10.7.1Company Overview ................................................................................... 120 All rights reserved at BIS Research Inc. 8

  9. 10.7.2Role of F. Hoffmann-La Roche Ltd in the Middle East Precision Medicine Market......................................................................................... 120 10.7.3Key Competitors of the Company ............................................................ 120 10.7.4Key Customers of the Company .............................................................. 120 10.7.5Business Strategies .................................................................................. 121 10.7.6Corporate Strategies ................................................................................. 121 10.7.7Key Insights about the Financial Health of the Company ...................... 124 10.7.8SWOT Analysis .......................................................................................... 125 10.8GlaxoSmithKline plc. ..................................................................................... 126 10.8.1Company Overview ................................................................................... 126 10.8.2Role of GlaxoSmithKline plc. in the Middle East Precision Medicine Market ......................................................................................................... 126 10.8.3Key Competitors of the Company ............................................................ 126 10.8.4Key Customers of the Company .............................................................. 126 10.8.5Financials ................................................................................................... 127 10.8.6Key Insights about the Financial Health of the Company ...................... 129 10.8.7SWOT Analysis .......................................................................................... 130 10.9Illumina, Inc. ................................................................................................... 131 10.9.1Company Overview ................................................................................... 131 10.9.2Role of Illumina, Inc. in the Middle East Precision Medicine Market .... 131 10.9.3Key Competitors of the Company ............................................................ 131 MIDDLE EAST PRECISION MEDICINE MARKET 10.9.4Key Customers of the Company .............................................................. 131 10.9.5Financials ................................................................................................... 132 10.9.6Key Insights about the Financial Health of the Company ...................... 134 10.9.7SWOT Analysis .......................................................................................... 135 10.10Intomics .......................................................................................................... 136 10.10.1 Company Overview ............................................................................. 136 10.10.2 Role Intomics in the Middle East Precision Medicine Market ......... 136 10.10.3 Key Competitors of the Company ..................................................... 136 10.10.4 Key Customers of the Company ........................................................ 136 All rights reserved at BIS Research Inc. 9

  10. 10.10.5 SWOT Analysis .................................................................................... 137 10.11Merck KGaA ................................................................................................... 138 10.11.1 Company Overview ............................................................................. 138 10.11.2 Role of Merck KGaA in the Middle East Precision Medicine Market ......................................................................................................... 138 10.11.3 Key Competitors of the Company ..................................................... 139 10.11.4 Key Customers of the Company ........................................................ 139 10.11.5 Financials ............................................................................................ 139 10.11.6 Key Insights about the Financial Health of the Company ............... 141 10.11.7 SWOT Analysis .................................................................................... 142 10.12Novartis AG .................................................................................................... 143 10.12.1 Company Overview ............................................................................. 143 10.12.2 Role of Novartis AG in the Middle East Precision Medicine Market ......................................................................................................... 143 10.12.3 Key Competitors of the Company ..................................................... 143 10.12.4 Key Customers of the Company ........................................................ 143 10.12.5 Financials ............................................................................................ 144 10.12.6 Key Insights about the Financial Health of the Company ............... 146 10.12.7 SWOT Analysis .................................................................................... 147 10.13Thermo Fisher Scientific Inc. ........................................................................ 148 10.13.1 Company Overview ............................................................................. 148 MIDDLE EAST PRECISION MEDICINE MARKET 10.13.2 Role of Thermo Fisher Scientific Inc. in the Middle East Precision Medicine Market ....................................................................... 148 10.13.3 Key Competitors of the Company ..................................................... 149 10.13.4 Key Customers of the Company ........................................................ 149 10.13.5 Financials ............................................................................................ 150 10.13.6 Key Insights about the Financial Health of the Company ............... 152 10.13.7 SWOT Analysis .................................................................................... 153 All rights reserved at BIS Research Inc. 10

  11. List of Figures Figure 1: Decreasing Cost and Increasing Output (TB) of Genome Sequencing, 2009-2025 Figure 2: Middle East Precision Medicine Market Segmentation Figure 3: Primary Research Methodology Figure 4: Bottom-Up Approach (Segment-Wise Analysis) Figure 5: COVID-19 Impact on the Middle East Precision Medicine Market Figure 6: Patent Analysis Figure 7: Role of FDA in Advancing Precision Medicine Figure 8: Synergistic Activities Share (by Company), January 2012-July 2020 Figure 9: Product Launches, Enhancements, and Upgradation Share (by Company), January 2012-July 2020 Figure 10: Mergers and Acquisitions Share (by Company), January 2012-July 2020 Figure 11: Business Expansion Share (by Company), January 2012-July 2020 Figure 12: Precision Medicine Ecosystem Figure 13: Middle East Precision Medicine Market (Applied Sciences) Figure 14: Middle East Precision Medicine Market (Applied Sciences), $Million, 2021-2032 Figure 15: Middle East Precision Medicine Market (by Applied Sciences), $Million, 2021-2032 Figure 16: Middle East Precision Medicine Market (Precision Therapeutics), $Million, 2021-2032 Figure 17: Middle East Precision Medicine Market (by Precision Therapeutics), $Million, 2021 and 2032 Figure 18: Middle East Precision Medicine Market (Digital Health and Information Technology), $Million, 2021-2032 Figure 19: Middle East Precision Medicine Market (by Digital Health and Information Technology), MIDDLE EAST PRECISION MEDICINE MARKET $Million, 2021 and 2032 Figure 20: Middle East Precision Medicine Market (Precision Diagnostics) Figure 21: Middle East Precision Medicine Market (Precision Diagnostics), $Million, 2021-2032 Figure 22: Middle East Precision Medicine Diagnostics Market (by Precision Diagnostics), $Million, 2021- 2032 Figure 23: Middle East Precision Medicine Market (by Application) Figure 24: Middle East Precision Medicine Market (by Application), $Million, 2021 and 2032 Figure 25: Types of Cancer Figure 26: Middle East Precision Medicine Market (Oncology), $Million, 2021-2032 Figure 27: Middle East Precision Medicine Market (Infectious Diseases), $Million, 2021-2032 All rights reserved at BIS Research Inc. 11

  12. Figure 28: Clinical Trials Number in the Middle East, 2010 and 2020 Figure 29: Middle East Precision Medicine Market (Neurology), $Million, 2021-2032 Figure 30: Middle East Precision Medicine Market (Endocrinology), $Million, 2021-2032 Figure 31: Middle East Precision Medicine Market (Cardiology), $Million, 2021-2032 Figure 32: Middle East Precision Medicine Market (Gastroenterology), $Million, 2021-2032 Figure 33: Middle East Precision Medicine Market (Other Applications), $Million, 2021-2032 Figure 34: Middle East Precision Medicine Market (by End User) Figure 35: Middle East Precision Medicine Market (by End User), $Million, 2021 and 2032 Figure 36: Middle East Precision Medicine Market, (Biopharmaceutical Companies), $Million, 2021-2032 Figure 37: Middle East Precision Medicine Market (Diagnostic Companies), $Million, 2021-2032 Figure 38: Middle East Precision Medicine Market (Other End Users), $Million, 2021-2032 Figure 39: Middle East Precision Medicine Market (by Country), $Million, 2021-2032 Figure 40: Middle East Precision Medicine Market (by Country), $Million, 2021 and 2032 Figure 41: Middle East Precision Medicine Market (K.S.A.), $Million, 2021-2032 Figure 42: Middle East Precision Medicine Market (Israel), $Million, 2021-2032 Figure 43: Middle East Precision Medicine Market (U.A.E.), $Million, 2021-2032 Figure 44: Middle East Precision Medicine Market (Egypt), $Million, 2021-2032 Figure 45: Middle East Precision Medicine Market (Iran), $Million, 2021-2032 Figure 46: Middle East Precision Medicine Market (Qatar), $Million, 2021-2032 Figure 47: Middle East Precision Medicine Market (Other Countries), $Million, 2021-2032 Figure 48: Total Number of Companies Profiled Figure 49: Abbott.: Overall Product Portfolio MIDDLE EAST PRECISION MEDICINE MARKET Figure 50: Abbott.: Overall Financials, $Million, 2019-2021 Figure 51: Abbott.: Revenue (by Segment), $Million, 2019-2021 Figure 52: Abbott.: Revenue (by Region), $Million, 2019-2021 Figure 53: Abbott.: R&D Expenditure, $Million, 2019-2021 Figure 54: Abbott.: SWOT Analysis Figure 55: Bio-Rad Laboratories, Inc.: Overall Product Portfolio Figure 56: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021 Figure 57: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 58: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 59: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 60: Bio-Rad Laboratories, Inc.: SWOT Analysis All rights reserved at BIS Research Inc. 12

  13. Figure 61: ASURAGEN, INC.: Overall Product Portfolio Figure 62: ASURAGEN, INC.: SWOT Analysis Figure 63: bioMérieux SA: Product Portfolio Figure 64: bioMérieux SA: Overall Financials, $Million, 2019-2021 Figure 65: bioMérieux SA: Revenue (by Segment), $Million, 2019-2021 Figure 66: bioMérieux SA: Revenue (by Region), $Million, 2019-2021 Figure 67: bioMérieux SA: R&D Expenditure, $Million, 2019-2021 Figure 68: bioMérieux SA: SWOT Analysis Figure 69: Diginova Health Solutions Ltd.: Product Portfolio Figure 70: Diginova Health Solutions Ltd.: SWOT Analysis Figure 71: F. Hoffmann-La Roche Ltd: Overall Product Portfolio Figure 72: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021 Figure 73: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021 Figure 74: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021 Figure 75: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021 Figure 76: F. Hoffmann-La Roche Ltd: SWOT Analysis Figure 77: GlaxoSmithKline plc.: Overall Product Portfolio Figure 78: GlaxoSmithKline plc.: Overall Financials, $Million, 2019-2021 Figure 79: GlaxoSmithKline plc.: Revenue (by Segment), $Million, 2019-2021 Figure 80: GlaxoSmithKline plc.: Revenue (by Region), $Million, 2019-2021 Figure 81: GlaxoSmithKline plc.: R&D Expenditure, $Million, 2019-2021 Figure 82: GlaxoSmithKline plc.: SWOT Analysis MIDDLE EAST PRECISION MEDICINE MARKET Figure 83: Illumina, Inc.: Product Portfolio Figure 84: Illumina, Inc.: Overall Financials, $Million, 2019-2021 Figure 85: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 86: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 87: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 88: Illumina, Inc.: SWOT Analysis Figure 89: Intomics: SWOT Analysis Figure 90: Merck KGaA: Product Portfolio Figure 91: Merck KGaA: Overall Financials, $Million, 2019-2021 Figure 92: Merck KGaA: Revenue (by Segment), $Million, 2019-2021 Figure 93: Merck KGaA: Revenue (by Region), $Million, 2019-2021 All rights reserved at BIS Research Inc. 13

  14. Figure 94: Merck KGaA: R&D Expenditure, $Million, 2019-2021 Figure 95: Merck KGaA: SWOT Analysis Figure 96: Novartis AG: Overall Product Portfolio Figure 97: Novartis AG: Overall Financials, $Million, 2019-2021 Figure 98: Novartis AG: Revenue (by Segment), $Million, 2019-2021 Figure 99: Novartis AG: Revenue (by Region), $Million, 2019-2021 Figure 100: Novartis AG: R&D Expenditure, $Million, 2019-2021 Figure 101: Novartis AG: SWOT Analysis Figure 102: Thermo Fisher Scientific Inc.: Product Portfolio Figure 103: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021 Figure 104: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 105: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021 Figure 106: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021 Figure 107: Thermo Fisher Scientific Inc.: SWOT Analysis MIDDLE EAST PRECISION MEDICINE MARKET All rights reserved at BIS Research Inc. 14

  15. List of Tables Table 1: Estimated Number of Cancer Incident Cases, 2018 and 2040 MIDDLE EAST PRECISION MEDICINE MARKET All rights reserved at BIS Research Inc. 15

  16. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More MIDDLE EAST PRECISION MEDICINE MARKET Know More All rights reserved at BIS Research Inc. 16

  17. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 MIDDLE EAST PRECISION MEDICINE MARKET All rights reserved at BIS Research Inc. 17

  18. MIDDLE EAST PRECISION MEDICINE MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com All rights reserved at BIS Research Inc. 18

More Related